AQEMIA

Inventing New Drugs at Scale with AI and Physics

Paris, France · Founded 2019 · $144.3M raised

Headquarters
Paris
Employees
51–200
Founded
2019
Business Model
B2B
Website
aqemia.com
Total Funding
$144.3M
Last Round
$7.4M GrantApr 2025
Rounds
6

About

AQEMIA is a Paris-based pharmatech company founded in 2019 that combines atomic-scale physics algorithms and generative AI to accelerate drug discovery. Its platform, rooted in over 12 years of academic research at CNRS and École Normale Supérieure, eliminates the need for experimental training data to predict drug-target affinities. AQEMIA runs internal and partnered programs in oncology and other high-need therapeutic areas, with collaborations including Sanofi and Servier.

Summary

AQEMIA is an Artificial Intelligence company based in Paris, France, founded in 2019. It has raised $144.3M in total across 6 rounds, most recently a $7.4M Grant round in Apr 2025. Investors include Elaia, Eurazeo and Bpifrance.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

GrantApr 2025
$7.4M

Sign up to see all 6 rounds

Pre-Seed through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AQEMIA on Indexed.vc
<a href="https://indexed.vc/companies/aqemia"><img src="https://indexed.vc/api/badge/company/aqemia" alt="AQEMIA on Indexed.vc" width="260" height="76" /></a>